These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 34519297

  • 1. Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs.
    Yao H, Gunawan YF, Liu G, Tse MK, Zhu G.
    Dalton Trans; 2021 Oct 12; 50(39):13737-13747. PubMed ID: 34519297
    [Abstract] [Full Text] [Related]

  • 2. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.
    Yao H, Chen S, Deng Z, Tse MK, Matsuda Y, Zhu G.
    Inorg Chem; 2020 Aug 17; 59(16):11823-11833. PubMed ID: 32799491
    [Abstract] [Full Text] [Related]

  • 3. Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity.
    Spector D, Bubley A, Zharova A, Bykusov V, Skvortsov D, Ipatova D, Erofeev A, Gorelkin P, Vaneev A, Mazur D, Nikitina V, Melnikov M, Pergushov V, Bunin D, Kuzmin V, Kostyukov A, Egorov A, Beloglazkina E, Akasov R, Krasnovskaya O.
    ACS Appl Bio Mater; 2024 May 20; 7(5):3431-3440. PubMed ID: 38697834
    [Abstract] [Full Text] [Related]

  • 4. Biotin-Pt(IV)-Ru(II)-Boron-Dipyrromethene Prodrug as "Platin Bullet" for Targeted Chemo- and Photodynamic Therapy.
    Bera A, Nepalia A, Upadhyay A, Saini DK, Chakravarty AR.
    Inorg Chem; 2024 Sep 16; 63(37):17249-17262. PubMed ID: 39235210
    [Abstract] [Full Text] [Related]

  • 5. The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
    Göschl S, Varbanov HP, Theiner S, Jakupec MA, Galanski MS, Keppler BK.
    J Inorg Biochem; 2016 Jul 16; 160():264-74. PubMed ID: 27055943
    [Abstract] [Full Text] [Related]

  • 6. Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine.
    Harringer S, Hejl M, Enyedy ÉA, Jakupec MA, Galanski MS, Keppler BK, Dyson PJ, Varbanov HP.
    Dalton Trans; 2021 Jun 21; 50(23):8167-8178. PubMed ID: 34031671
    [Abstract] [Full Text] [Related]

  • 7. Cell-permeable lanthanide-platinum(IV) anti-cancer prodrugs.
    Yao K, Karunanithy G, Howarth A, Holdship P, Thompson AL, Christensen KE, Baldwin AJ, Faulkner S, Farrer NJ.
    Dalton Trans; 2021 Jun 29; 50(25):8761-8767. PubMed ID: 34080595
    [Abstract] [Full Text] [Related]

  • 8. Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.
    Varbanov HP, Valiahdi SM, Kowol CR, Jakupec MA, Galanski MS, Keppler BK.
    Dalton Trans; 2012 Dec 21; 41(47):14404-14415. PubMed ID: 22886297
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
    Xu Z, Chan HM, Li C, Wang Z, Tse MK, Tong Z, Zhu G.
    Inorg Chem; 2018 Jul 16; 57(14):8227-8235. PubMed ID: 29943979
    [Abstract] [Full Text] [Related]

  • 10. Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs.
    Shi H, Romero-Canelón I, Hreusova M, Novakova O, Venkatesh V, Habtemariam A, Clarkson GJ, Song JI, Brabec V, Sadler PJ.
    Inorg Chem; 2018 Nov 19; 57(22):14409-14420. PubMed ID: 30365308
    [Abstract] [Full Text] [Related]

  • 11. Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs.
    Marsh JW, Hacker L, Huang S, Boulet MHC, White JRG, Martin LAW, Yeomans MA, Han HH, Diez-Perez I, Musgrave RA, Hammond EM, Sedgwick AC.
    Dalton Trans; 2024 Sep 10; 53(35):14811-14816. PubMed ID: 39169877
    [Abstract] [Full Text] [Related]

  • 12. Highly Emissive Self-Assembled BODIPY-Platinum Supramolecular Triangles.
    Zhou J, Zhang Y, Yu G, Crawley MR, Fulong CRP, Friedman AE, Sengupta S, Sun J, Li Q, Huang F, Cook TR.
    J Am Chem Soc; 2018 Jun 20; 140(24):7730-7736. PubMed ID: 29787269
    [Abstract] [Full Text] [Related]

  • 13. Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug.
    Lee KGZ, Babak MV, Weiss A, Dyson PJ, Nowak-Sliwinska P, Montagner D, Ang WH.
    ChemMedChem; 2018 Jun 20; 13(12):1210-1217. PubMed ID: 29637702
    [Abstract] [Full Text] [Related]

  • 14. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
    Babu T, Sarkar A, Karmakar S, Schmidt C, Gibson D.
    Inorg Chem; 2020 Apr 06; 59(7):5182-5193. PubMed ID: 32207294
    [Abstract] [Full Text] [Related]

  • 15. Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery.
    Zheng YR, Suntharalingam K, Johnstone TC, Yoo H, Lin W, Brooks JG, Lippard SJ.
    J Am Chem Soc; 2014 Jun 18; 136(24):8790-8. PubMed ID: 24902769
    [Abstract] [Full Text] [Related]

  • 16. Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.
    Papadia P, Micoli K, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N.
    Int J Mol Sci; 2020 Mar 27; 21(7):. PubMed ID: 32230896
    [Abstract] [Full Text] [Related]

  • 17. Pt(IV) Anticancer Prodrugs - A Tale of Mice and Men.
    Gibson D.
    ChemMedChem; 2021 Jul 20; 16(14):2188-2191. PubMed ID: 33928760
    [Abstract] [Full Text] [Related]

  • 18. Design and investigation of photoactivatable platinum(iv) prodrug complexes of cisplatin.
    Lee VEY, Chin CF, Ang WH.
    Dalton Trans; 2019 Jun 07; 48(21):7388-7393. PubMed ID: 30957798
    [Abstract] [Full Text] [Related]

  • 19. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H.
    Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585
    [Abstract] [Full Text] [Related]

  • 20. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Xu Z, Wang Z, Yiu SM, Zhu G.
    Dalton Trans; 2015 Dec 14; 44(46):19918-26. PubMed ID: 26514681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.